- Drug Manufacturers - General
- Healthcare
Amgen Inc.
AMGN · US ·
NASDAQ
324.69
USD
+12.19
(3.75%)
-
5.83
EPS
-
55.71
P/E
-
174B
MARKET CAP
-
2.70%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 7.31 | 20.1 | 18.3 | 20.3 | 23 | 23.5 | 26.35% |
| Avg. Estimate | 7.03 | 19.5 | 12.4 | 13.8 | 22.1 | 22.6 | 26.35% |
| Low Estimate | 6.77 | 19.3 | 9.31 | 10.1 | 21.3 | 21.8 | 26.35% |
| No. Of Analysts | 17 | 20 | 17 | 9 | 7 | 4 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 29.7B | 33.4B | 35.5B | 35.9B | 36.3B | 36.8B | 4.35% |
| Avg. Estimate | 29.5B | 33.2B | 34.1B | 34.8B | 35.2B | 35.6B | 3.84% |
| Low Estimate | 29.4B | 32.8B | 33.2B | 33.8B | 34.3B | 34.7B | 3.37% |
| No. Of Analysts | 20 | 19 | 21 | 22 | 12 | 10 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 4.52B | 10.8B | 9.83B | 10.9B | 12.4B | 12.7B | 22.92% |
| Avg. Estimate | 3.76B | 10.5B | 6.28B | 6.99B | 11.9B | 12.2B | 26.47% |
| Low Estimate | 3.01B | 10.4B | 5.01B | 5.43B | 11.5B | 11.7B | 31.28% |
| No. Of Analysts | 20 | 19 | 21 | 22 | 12 | 10 |